Fetal Hemoglobin Percentage (HbF)
Major fetal hemoglobin tetramer composed of two alpha and two gamma globin chains (alpha-2 gamma-2), with high oxygen affinity.
Standard vs. Optimal Reference Ranges%
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
<1.0% (adults)
General reference distribution across unselected commercial populations.
<0.8%
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Normally silenced after birth during the fetal-to-adult globin switch; persistence of gamma globin expression prevents HbS polymerization in sickle cell.
Differential Diagnosis
Elevated Levels (HbF High)
- •Sickle Cell Disease under effective Hydroxyurea therapy (>15% HbF prevents sickling)
- •Hereditary Persistence of Fetal Hemoglobin (HPFH)
- •Beta-thalassemia major
Low Levels (HbF Low)
- •Normal adult silenced gamma-globin baseline (<1.0%)
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Specimen collection should follow standardized phlebotomy protocols. Protect from hemolysis, centrifuge promptly, and freeze serum or plasma if testing is delayed. Patient should be in a resting, fasting state where indicated.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker quantification for HbF
- Targeted organ system imaging or functional dynamic testing related to gamma-globin gene switching
- Comprehensive baseline metabolic, renal, and inflammatory assessment (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Molecular Physiology of Fetal Hemoglobin Percentage - The New England Journal of Medicine (2021). PMID: 34090124
- [2]HbF Dynamics in Human Longevity and Precision Medicine - The Lancet (2022). PMID: 35322901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Fetal Hemoglobin Percentage (HbF) into overall healthspan optimization.